buy microsoft windows 7 professional 64 buy pdf converter best price windows 7 enterprise best price adobe cs4 production premium adobe cs3 master collection price buy microsoft mappoint 2010 online autodesk 3ds max student discount purchase windows xp cheap buy dragon naturally speaking 10 essentials buy paperport 8 best price office 2007 small business upgrade best price acrobat 9 extended buy 2003 server software price of windows 7 home basic buy powerpoint 2007 cheap purchase outlook 2007 separately buy reason 4.0 1 buy wordperfect office x4 standard edition buy windows seven cheap buy vmware fusion cheap buy adobe after effects 6.5 best buy auditions cheapest adobe fireworks where to buy adobe photoshop 7.0 cheapest pinnacle studio 12 ultimate buy cs3 adobe cheap painter 10 buy 2003 server software buy canon 580ex flash purchase sam 2010 access code

Germany’s Merck halts supply of cancer drug to Greek hospitals

Mon, Nov 5, 2012

Oral Cancer News


Date: November 3, 2012

German pharmaceuticals firm Merck KGaA is no longer delivering cancer drug Erbitux to Greek hospitals, a spokesman said on Saturday, the latest sign of how an economic and budget crisis is hurting frontline public services.

Drugmakers raised concerns with EU leaders earlier this year over supplies to the euro zone’s crisis-hit southern half and Germany’s Biotest in June was the first to stop shipments to Greece because of unpaid bills.

Publicly-owned hospitals in some countries worst hit by the euro zone debt crisis had been struggling to pay their bills, Merck’s chief financial officer, Matthias Zachert, was quoted as saying by German paper Boersen-Zeitung in an interview on Saturday.

He said however that the only country where Merck had stopped deliveries was Greece.

“It only affects Greece, where we have been faced with many problems. It’s just the one product,” he told the paper.

A spokesman for the company told Reuters that the drug concerned was Erbitux and that ordinary Greeks can still purchase it from pharmacies.

Some countries have taken action to pay bills, such as in Spain, where the government has said it will help hospitals to pay off debts.

“That has improved things, even though the situation should still be regarded as critical for the coming years,” Zachert said.

Erbitux is Merck’s second best-selling prescription drug, bringing in sales of 855 million euros ($1.1 billion) in 2011 from treating bowel cancer and head and neck cancer. ($1 = 0.7785 euros)

This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

Print Friendly
Be Sociable, Share!
, , ,

Leave a Reply

You must be logged in to post a comment.